| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-02973-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61776-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61700-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61861-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2648-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB200-125SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-98881-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-98754-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89251-50ul | |||
![Immunocytochemistry/Immunofluorescence: PD-L1 Antibody (F2G2) - VHH [NBP3-12826] - Immunofluorescence of PD-L1 in transfected 293 cells with PD-L1 antibody at 10 ug/ml. Green: PD-L1 Antibody [F2G2] Blue: DAPI staining](http://images.novusbio.com/fullsize/PD-L1-Antibody-F2G2-VHH-Immunocytochemistry-Immunofluorescence-NBP3-12826-img0002.jpg "Immunocytochemistry/Immunofluorescence: PD-L1 Antibody (F2G2) - VHH [NBP3-12826] - Immunofluorescence of PD-L1 in transfected 293 cells with PD-L1 antibody at 10 ug/ml. Green: PD-L1 Antibody [F2G2] Blue: DAPI staining")
![Immunocytochemistry/Immunofluorescence: PD-L1 Antibody (F2G2) - VHH [NBP3-12826] - Immunocytochemistry of PD-L1 in transfected 293 cells with PD-L1 antibody at 10 ug/ml.](http://images.novusbio.com/fullsize/PD-L1-Antibody-F2G2-VHH-Immunocytochemistry-Immunofluorescence-NBP3-12826-img0003.jpg)
![ELISA: PD-L1 Antibody (F2G2) - VHH [NBP3-12826] - Titration ELISA of PD-L1.](http://images.novusbio.com/fullsize/PD-L1-Antibody-F2G2-VHH-ELISA-NBP3-12826-img0001.jpg)
![Western Blot: ERK2 Antibody [NBP3-02973] - Western blot analysis of extracts from normal (control) and ERK2 knockout (KO) HeLa cells, using ERK2 antibody (NBP3-02973) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/ERK2-Antibody-Western-Blot-NBP3-02973-img0001.jpg "<b>Genetic Strategies Validation. </b>Western Blot: ERK2 Antibody [NBP3-02973] - Western blot analysis of extracts from normal (control) and ERK2 knockout (KO) HeLa cells, using ERK2 antibody (NBP3-02973) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![<b>Genetic Strategies Validation. </b>Western Blot: ERK2 Antibody [NBP3-02973] - Western blot analysis of extracts of various cell lines, using ERK2 antibody (NBP3-02973) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/ERK2 Antibody-Western Blot-NBP3-02973-img0002.jpg)
![Western Blot: GluR2 Antibody (7A7D12) [NBP2-61776] - Analysis using GRIA2 mAb against human GRIA2 (AA: 35-175) recombinant protein. (Expected MW is 41.9 kDa)](http://images.novusbio.com/fullsize/GluR2-Antibody-7A7D12-Western-Blot-NBP2-61776-img0003.jpg "Western Blot: GluR2 Antibody (7A7D12) [NBP2-61776] - Analysis using GRIA2 mAb against human GRIA2 (AA: 35-175) recombinant protein. (Expected MW is 41.9 kDa)")
![Western Blot: GluR2 Antibody (7A7D12) [NBP2-61776] - Analysis using GRIA2 mAb against HEK293 (1) and GRIA2 (AA: 35-175)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/GluR2-Antibody-7A7D12-Western-Blot-NBP2-61776-img0004.jpg)
![ELISA: GluR2 Antibody (7A7D12) [NBP2-61776] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/GluR2-Antibody-7A7D12-ELISA-NBP2-61776-img0001.jpg)
![ELISA: GluR2 Antibody (7A7D12) [NBP2-61776] - Analysis of SK-N-SH cells using GRIA2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/GluR2-Antibody-7A7D12-ELISA-NBP2-61776-img0002.jpg)
![Western Blot: BCL11B Antibody (1F8H9) [NBP2-61700] - Analysis using BCL11B mAb against human BCL11B (AA: 1-150) recombinant protein. (Expected MW is 42.3 kDa)](http://images.novusbio.com/fullsize/BCL11B-Antibody-1F8H9-Western-Blot-NBP2-61700-img0003.jpg "Western Blot: BCL11B Antibody (1F8H9) [NBP2-61700] - Analysis using BCL11B mAb against human BCL11B (AA: 1-150) recombinant protein. (Expected MW is 42.3 kDa)")
![Flow Cytometry: BCL11B Antibody (1F8H9) [NBP2-61700] - Analysis of BCL11B cells using HeLa mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/BCL11B-Antibody-1F8H9-Flow-Cytometry-NBP2-61700-img0002.jpg)
![Western Blot: BCL11B Antibody (1F8H9) [NBP2-61700] - Analysis using BCL11B mAb against HEK293 (1) and BCL11B (AA: 1-150)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/BCL11B-Antibody-1F8H9-Western-Blot-NBP2-61700-img0004.jpg)
![ELISA: BCL11B Antibody (1F8H9) [NBP2-61700] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/BCL11B-Antibody-1F8H9-ELISA-NBP2-61700-img0001.jpg)
![Western Blot: PAWR / PAR4 Antibody (3G9H7) [NBP1-28892] - PAWR / PAR4 Antibody (3G9H7) Western blot analysis using PAR4 mouse mAb against full-length Trx-Par4 recombinant protein (1) and Hela cell lysate (2).](http://images.novusbio.com/fullsize/PAWR-PAR4-Antibody-3G9H7-Western-Blot-NBP1-28892-img0006.jpg "Western Blot: PAWR / PAR4 Antibody (3G9H7) [NBP1-28892] - PAWR / PAR4 Antibody (3G9H7) Western blot analysis using PAR4 mouse mAb against full-length Trx-Par4 recombinant protein (1) and Hela cell lysate (2).")
![Immunohistochemistry-Paraffin: PAWR / PAR4 Antibody (3G9H7) [NBP1-28892] - Analysis of human brain (left) and breast carcinoma (right), showing cytoplasmic and membrane localization using PAR4 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/PAWR-PAR4-Antibody-3G9H7-Immunohistochemistry-Paraffin-NBP1-28892-img0005.jpg)
![Immunohistochemistry-Paraffin: PAWR / PAR4 Antibody (3G9H7) [NBP1-28892] - Analysis of human Small Intestine tissues using PAR4 mouse mAb.](http://images.novusbio.com/fullsize/PAWR-PAR4-Antibody-3G9H7-Immunohistochemistry-Paraffin-NBP1-28892-img0004.jpg)
![Western Blot: RUNX1/CBFA2 Antibody (6C12A5) [NBP2-61861] - Analysis using RUNX1 mAb against human RUNX1 (AA: 237-337) recombinant protein. (Expected MW is 36.9 kDa)](http://images.novusbio.com/fullsize/RUNX1-CBFA2-Antibody-6C12A5-Western-Blot-NBP2-61861-img0003.jpg "Western Blot: RUNX1/CBFA2 Antibody (6C12A5) [NBP2-61861] - Analysis using RUNX1 mAb against human RUNX1 (AA: 237-337) recombinant protein. (Expected MW is 36.9 kDa)")
![Flow Cytometry: RUNX1/CBFA2 Antibody (6C12A5) [NBP2-61861] - Analysis of K562 cells using RUNX1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/RUNX1-CBFA2-Antibody-6C12A5-Flow-Cytometry-NBP2-61861-img0002.jpg)
![Western Blot: RUNX1/CBFA2 Antibody (6C12A5) [NBP2-61861] - Analysis using RUNX1 mAb against HEK293 (1) and RUNX1 (AA: 237-337)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/RUNX1-CBFA2-Antibody-6C12A5-Western-Blot-NBP2-61861-img0004.jpg)
![ELISA: RUNX1/CBFA2 Antibody (6C12A5) [NBP2-61861] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/RUNX1-CBFA2-Antibody-6C12A5-ELISA-NBP2-61861-img0001.jpg)
![Immunohistochemistry-Paraffin: Laminin Antibody (4C7) [NB120-17107] - Analysis in formalin fixed paraffin embedded renal carcinoma stained with Laminin Antibody (4C7) [NB120-17107].](http://images.novusbio.com/fullsize/Laminin-Antibody-4C7-Immunohistochemistry-Paraffin-NB120-17107-img0002.jpg "Immunohistochemistry-Paraffin: Laminin Antibody (4C7) [NB120-17107] - Analysis in formalin fixed paraffin embedded renal carcinoma stained with Laminin Antibody (4C7) [NB120-17107].")
![Immunohistochemistry-Paraffin: Laminin Antibody (4C7) [NB120-17107] - Analysis in formalin fixed paraffin embedded renal carcinoma with Laminin Antibody (4C7) [NB120-17107].](http://images.novusbio.com/fullsize/Laminin-Antibody-4C7-Immunohistochemistry-Paraffin-NB120-17107-img0001.jpg)
![Western Blot: p16INK4a/CDKN2A Antibody [NBP2-98881] - Anti-p16INK4a/CDKN2A rabbit polyclonal antibody at 1:500 dilution. Lane A: Hela Whole Cell Lysate. Lane B: 293T Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 17 kDa. Observed band size: 17 kDa](http://images.novusbio.com/fullsize/p16INK4a-CDKN2A-Antibody-Western-Blot-NBP2-98881-img0005.jpg "Western Blot: p16INK4a/CDKN2A Antibody [NBP2-98881] - Anti-p16INK4a/CDKN2A rabbit polyclonal antibody at 1:500 dilution. Lane A: Hela Whole Cell Lysate. Lane B: 293T Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 17 kDa. Observed band size: 17 kDa")
![Immunoprecipitation: p16INK4a/CDKN2A Antibody [NBP2-98881] - p16INK4a/CDKN2A was immunoprecipitated using: Lane A: 0.5 mg Hela Whole Cell Lysate. Lane B: 0.5 mg 293T Whole Cell Lysate 2 ul anti-p16INK4a/CDKN2A rabbit polyclonal antibody and 60 ug of Immunomagnetic beads Protein G. Primary antibody: Anti-p16INK4a/CDKN2A rabbit polyclonal antibody, at 1:200 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 17 kDa. Observed band size: 17 kDa](http://images.novusbio.com/fullsize/p16INK4a-CDKN2A-Antibody-Immunoprecipitation-NBP2-98881-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: p16INK4a/CDKN2A Antibody [NBP2-98881] - Immunofluorescence staining of p16INK4a/CDKN2A in HeLa cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-98881 antibody (1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor(R)594-conjugated Goat Anti-rabbit IgG secondary antibody (red). Positive staining was localized to cytoplasm and nucleus.](http://images.novusbio.com/fullsize/nbp2-98881_rabbit-polyclonal-p16ink4a-cdkn2a-antibody-235202512205526.png)
![Immunohistochemistry-Paraffin: Carm1 Antibody [NBP2-98754] - Immunochemical staining of human Carm1 in human ovarian cancer with rabbit polyclonal antibody (1:2000, formalin-fixed paraffin embedded sections).](http://images.novusbio.com/fullsize/Carm1-Antibody-Immunohistochemistry-Paraffin-NBP2-98754-img0003.jpg "Immunohistochemistry-Paraffin: Carm1 Antibody [NBP2-98754] - Immunochemical staining of human Carm1 in human ovarian cancer with rabbit polyclonal antibody (1:2000, formalin-fixed paraffin embedded sections).")
![Immunohistochemistry-Paraffin: Carm1 Antibody [NBP2-98754] - Immunochemical staining of human Carm1 in human prostatic carcinoma with rabbit polyclonal antibody (1:2000, formalin-fixed paraffin embedded sections).](http://images.novusbio.com/fullsize/Carm1-Antibody-Immunohistochemistry-Paraffin-NBP2-98754-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: Carm1 Antibody [NBP2-98754] - Immunofluorescence staining of Carm1 in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-98754 antibody (1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor(R)594-conjugated Goat Anti-rabbit IgG secondary antibody (red). Positive staining was localized to cytoplasm and nucleus.](http://images.novusbio.com/fullsize/nbp2-98754_rabbit-polyclonal-carm1-antibody-23520251628120.png)
![Western Blot: SMAC/Diablo Antibody (006) [NBP2-89251] - NBP2-89251 at 1:10000 dilution Lane A: Hela Whole Cell Lysate Lane B: Jurkat Whole Cell Lysate Lane C: A431 Whole Cell Lysate Lane D: MCF7 Whole Cell Lysate Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:22 kDa Observed band size:20 kDa](http://images.novusbio.com/fullsize/nbp2-89251_rabbit-monoclonal-smac-diablo-antibody-006-23520251129339.png "Western Blot: SMAC/Diablo Antibody (006) [NBP2-89251] - NBP2-89251 at 1:10000 dilution Lane A: Hela Whole Cell Lysate Lane B: Jurkat Whole Cell Lysate Lane C: A431 Whole Cell Lysate Lane D: MCF7 Whole Cell Lysate Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:22 kDa Observed band size:20 kDa")
![Flow Cytometry: SMAC/Diablo Antibody (006) [NBP2-89251] - Flow cytometric analysis of Human SMAC/Diablo expression on HeLa cells. The cells were treated, stained with NBP2-89251 (Filled histogram), then a FITC-conjugated second step antibody. To demonstrate specificity of staining, the binding by NBP2-89251 was blocked by preincubation of the purified antibody with 20ug recombinant human SMAC/Diablo for 1 hour (Black solid line hisgram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/nbp2-89251_rabbit-monoclonal-smac-diablo-antibody-006-235202514492353.png)
![Immunocytochemistry/ Immunofluorescence: SMAC/Diablo Antibody (006) [NBP2-89251] - Immunofluorescence staining of Human SMAC/Diablo in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-89251 (1:60) at 4 overnight. Then cells were stained with the Alexa Fluor 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp2-89251_rabbit-monoclonal-smac-diablo-antibody-006-235202511444460.png)